Form 4: Vericel Corp Officer Siegal Jonathan Reports Stock Option and Restricted Stock Unit Grants

Jonathan Siegal, Principal Accounting Officer of Vericel Corp, reports the acquisition of stock options and restricted stock units.

Summary

• On February 20, 2025, Jonathan Siegal, Principal Accounting Officer of Vericel Corp, was granted stock options for 6,600 shares and 6,160 restricted stock units (RSUs).
• The stock options have an exercise price of $54.31 and vest in equal quarterly installments over four years, starting February 20, 2025.
• The RSUs vest in four annual installments, beginning on February 20, 2026, and continuing on February 20, 2027, February 20, 2028, and February 20, 2029.
• Each RSU represents a contingent right to receive one share of Vericel Corporation common stock.
• Following these transactions, Siegal directly owns 6,600 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices that align management with shareholder interests.

Positives

• The grant of stock options and RSUs aligns the officer's interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the officer.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the options and RSUs.

Industry Context

This is a standard practice for publicly traded companies to incentivize and retain key personnel through equity-based compensation.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies, particularly in the biotech and pharmaceutical industries, to align management's interests with those of shareholders.
• Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options and RSUs as part of their compensation packages for executives and key employees.
• The vesting schedules and exercise prices are generally structured to incentivize long-term performance and retention.

Stakeholder Impact

• The grant of stock options and RSUs could potentially increase shareholder value if the officer's performance leads to company growth.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Vericel Corp, Siegal Jonathan, stock options, restricted stock units, RSU, Form 4, officer, Principal Accounting Officer, beneficial ownership, equity securities